Erratum: Control of ADAM17 activity by regulation of its cellular localisation (Scientific Reports (2016) 6 (35067) DOI: 10.1038/srep35067);Control of ADAM17 activity by regulation of its cellular localisation

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Lorenzen, Inken ^a   Lokau, Juliane ^a   Korpys, Yvonne ^a   Oldefest, Mirja ^a   Flynn, Charlotte M ^a   Künzel, Ulrike ^b   Garbers, Christoph ^a   Freeman, Matthew ^b   Grötzinger, Joachim ^a   Düsterhöft, Stefan ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

12-O-RETINOYLPHORBOL-13-ACETATE; ADAM17 PROTEIN, HUMAN; PHORBOL ESTER; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

CELL MEMBRANE; CLATHRIN-COATED VESICLE; DOWN REGULATION; DRUG EFFECTS; ENZYME ACTIVATION; HEK293 CELL LINE; HELA CELL LINE; HUMAN; METABOLISM; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

ADAM17 PROTEIN; CELL MEMBRANE; CLATHRIN-COATED VESICLES; DOWN-REGULATION; ENZYME ACTIVATION; HEK293 CELLS; HELA CELLS; HUMANS; PHORBOL ESTERS; PROTEIN KINASE C; PROTEOLYSIS; SIGNAL TRANSDUCTION;

EID: 84991075525     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep37364     Document Type: Erratum

References (48)

1. Gooz, M. ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol 45, 146-169, doi: 10. 3109/10409231003628015 (2010).
2. Düsterhöft, S. et al. Membrane-proximal domain of a disintegrin and metalloprotease-17 represents the putative molecular switch of its shedding activity operated by protein-disulfide isomerase. J Am Chem Soc 135, 5776-5781, doi: 10. 1021/ja400340u (2013).
3. Düsterhöft, S. et al. A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptor. J Biol Chem 289, 16336-16348, doi: 10. 1074/jbc. M114. 557322 (2014).
4. Black, R. A. et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733, doi: 10. 1038/385729a0 (1997).
5. Moss, M. L. et al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733-736, doi: 10. 1038/385733a0 (1997).
6. Chalaris, A. et al. Critical role of the disintegrin metalloprotease ADAM17 for intestinal inflammation and regeneration in mice. J Exp Med 207, 1617-1624, doi: 10. 1084/jem. 20092366 (2010).
7. Blaydon, D. C. et al. Inflammatory skin and bowel disease linked to ADAM17 deletion. N Engl J Med 365, 1502-1508, doi: 10. 1056/NEJMoa1100721 (2011).
8. Peschon, J. J. et al. An essential role for ectodomain shedding in mammalian development. Science 282, 1281-1284 (1998).
9. Scheller, J., Chalaris, A., Garbers, C., Rose-John, S. ADAM17: a molecular switch to control inflammation and tissue regeneration. Trends Immunol 32, 380-387, doi: 10. 1016/j. it. 2011. 05. 005 (2011).
10. Horiuchi, K. et al. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol Biol Cell 18, 176-188, doi: 10. 1091/mbc. E06-01-0014 (2007).
11. Reddy, P. et al. Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275, 14608-14614 (2000).
12. Müllberg, J. et al. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 23, 473-480, doi: 10. 1002/eji. 1830230226 (1993).
13. Jones, S. A., Scheller, J., Rose-John, S. Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 121, 3375-3383, doi: 10. 1172/JCI57158 (2011).
14. Arora, P., Cuevas, B. D., Russo, A., Johnson, G. L., Trejo, J. Persistent transactivation of EGFR and ErbB2/HER2 by proteaseactivated receptor-1 promotes breast carcinoma cell invasion. Oncogene 27, 4434-4445, doi: 10. 1038/onc. 2008. 84 (2008).
15. Xu, P., Derynck, R. Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptordependent cell proliferation. Mol Cell 37, 551-566, doi: 10. 1016/j. molcel. 2010. 01. 034 (2010).
16. Le Gall, S. M. et al. ADAM17 is regulated by a rapid and reversible mechanism that controls access to its catalytic site. J Cell Sci 123, 3913-3922, doi: 10. 1242/jcs. 069997 (2010).
17. Bennett, T. A., Edwards, B. S., Sklar, L. A., Rogelj, S. Sulfhydryl regulation of L-selectin shedding: phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes. J Immunol 164, 4120-4129 (2000).
18. Wang, Y., Herrera, A. H., Li, Y., Belani, K. K., Walcheck, B. Regulation of mature ADAM17 by redox agents for L-selectin shedding. J Immunol 182, 2449-2457, doi: 10. 4049/jimmunol. 0802770 (2009).
19. Düsterhöft, S. et al. Extracellular Juxtamembrane Segment of ADAM17 Interacts with Membranes and Is Essential for Its Shedding Activity. Biochemistry 54, 5791-5801, doi: 10. 1021/acs. biochem. 5b00497 (2015).
20. Sommer, A. et al. Phosphatidylserine exposure is required for ADAM17 sheddase function. Nat Commun 7, 11523, doi: 10. 1038/ncomms11523 (2016).
21. Endres, K. et al. Tumor necrosis factor-alpha converting enzyme is processed by proprotein-convertases to its mature form which is degraded upon phorbol ester stimulation. Eur J Biochem 270, 2386-2393 (2003).
22. Adrain, C., Zettl, M., Christova, Y., Taylor, N., Freeman, M. Tumor necrosis factor signaling requires iRhom2 to promote trafficking and activation of TACE. Science 335, 225-228, doi: 10. 1126/science. 1214400 (2012).
23. Christova, Y., Adrain, C., Bambrough, P., Ibrahim, A., Freeman, M. Mammalian iRhoms have distinct physiological functions including an essential role in TACE regulation. EMBO Rep 14, 884-890, doi: doi: 10. 1038/embor. 2013. 128 (2013).
24. McIlwain, D. R. et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 335, 229-232, doi: 10. 1126/science. 1214448 (2012).
25. Soond, S. M., Everson, B., Riches, D. W., Murphy, G. ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. J Cell Sci 118, 2371-2380, doi: 10. 1242/jcs. 02357 (2005).
26. Doedens, J. R., Black, R. A. Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J Biol Chem 275, 14598-14607, doi: 10. 1074/jbc. 275. 19. 14598 (2000).
27. Le Roy, C., Wrana, J. L. Clathrin-and non-clathrin-mediated endocytic regulation of cell signalling. Nat Rev Mol Cell Biol 6, 112-126, doi: 10. 1038/nrm1571 (2005).
28. Carpentier, J. L. et al. Potassium depletion and hypertonic medium reduce "non-coated" and clathrin-coated pit formation, as well as endocytosis through these two gates. J Cell Physiol 138, 519-526, doi: 10. 1002/jcp. 1041380311 (1989).
29. Dombernowsky, S. L. et al. The sorting protein PACS-2 promotes ErbB signalling by regulating recycling of the metalloproteinase ADAM17. Nat Commun 6, 7518, doi: 10. 1038/ncomms8518 (2015).
30. Diaz-Rodriguez, E., Montero, J. C., Esparis-Ogando, A., Yuste, L., Pandiella, A. Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell 13, 2031-2044, doi: 10.1091/mbc.01-11-0561 (2002).
31. Oldefest, M. et al. Secreted Frizzled-related protein 3 (sFRP3)-mediated suppression of interleukin-6 receptor release by A disintegrin and metalloprotease 17 (ADAM17) is abrogated in the osteoarthritis-associated rare double variant of sFRP3. Biochem J 468, 507-518, doi: 10. 1042/BJ20141231 (2015).
32. Caescu, C. I., Jeschke, G. R., Turk, B. E. Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J 424, 79-88, doi: 10. 1042/BJ20090549 (2009).
33. Zhao, X. et al. Expression of auxilin or AP180 inhibits endocytosis by mislocalizing clathrin: evidence for formation of nascent pits containing AP1 or AP2 but not clathrin. J Cell Sci 114, 353-365 (2001).
34. Miller, K., Shipman, M., Trowbridge, I. S., Hopkins, C. R. Transferrin receptors promote the formation of clathrin lattices. Cell 65, 621-632 (1991).
35. Tellier, E. et al. The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res 312, 3969-3980, doi: 10. 1016/j. yexcr. 2006. 08. 027 (2006).
36. Takaguri, A. et al. Caveolin-1 negatively regulates a metalloprotease-dependent epidermal growth factor receptor transactivation by angiotensin II. J Mol Cell Cardiol 50, 545-551, doi: 10. 1016/j. yjmcc. 2010. 12. 009 (2011).
37. Moreno-Caceres, J. et al. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-beta in hepatocytes requires activation of Src and the NADPH oxidase NOX1. FEBS J, doi: 10. 1111/febs. 13669 (2016).
38. Trowbridge, I. S., Collawn, J. F., Hopkins, C. R. Signal-dependent membrane protein trafficking in the endocytic pathway. Annu Rev Cell Biol 9, 129-161, doi: 10. 1146/annurev. cb. 09. 110193. 001021 (1993).
39. Luo, T., Fredericksen, B. L., Hasumi, K., Endo, A., Garcia, J. V. Human immunodeficiency virus type 1 Nef-induced CD4 cell surface downregulation is inhibited by ikarugamycin. J Virol 75, 2488-2492, doi: 10. 1128/JVI. 75. 5. 2488-2492. 2001 (2001).
40. Lee, J. H. et al. HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases. Mol Cell 49, 668-679, doi: 10. 1016/j. molcel. 2012. 12. 004 (2013).
41. Arenaccio, C. et al. Exosomes from human immunodeficiency virus type 1 (HIV-1)-infected cells license quiescent CD4+ T lymphocytes to replicate HIV-1 through a Nef-and ADAM17-dependent mechanism. J Virol 88, 11529-11539, doi: 10. 1128/JVI. 01712-14 (2014).
42. Testa, J. S., Apcher, G. S., Comber, J. D., Eisenlohr, L. C. Exosome-driven antigen transfer for MHC class II presentation facilitated by the receptor binding activity of influenza hemagglutinin. J Immunol 185, 6608-6616, doi: 10. 4049/jimmunol. 1001768 (2010).
43. Van Hauwermeiren, F., Vandenbroucke, R. E., Libert, C. Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1. Cytokine Growth Factor Rev 22, 311-319, doi: 10. 1016/j. cytogfr. 2011. 09. 004 (2011).
44. Richards, F. M., Tape, C. J., Jodrell, D. I., Murphy, G. Anti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivo. PLoS One 7, e40597, doi: 10. 1371/journal. pone. 0040597 (2012).
45. Trad, A. et al. Development of sandwich ELISA for detection and quantification of human and murine a disintegrin and metalloproteinase17. J Immunol Methods 371, 91-96, doi: 10. 1016/j. jim. 2011. 06. 015 (2011).
46. Yamamoto, K. et al. A novel bispecific single-chain antibody for ADAM17 and CD3 induces T-cell-mediated lysis of prostate cancer cells. Biochem J 445, 135-144, doi: 10. 1042/BJ20120433 (2012).
47. Trad, A. et al. ADAM17-overexpressing breast cancer cells selectively targeted by antibody-toxin conjugates. Cancer Immunol Immunother 62, 411-421, doi: 10. 1007/s00262-012-1346-x (2013).
48. Lorenzen, I. et al. The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II. FEBS Lett 586, 1093-1100, doi: 10. 1016/j. febslet. 2012. 03. 012 (2012).